R

Revolution Medicines
D

RVMD

41.360
USD
-0.89
(-2.11%)
مغلق
حجم التداول
34,330
الربح لكل سهم
-4
العائد الربحي
-
P/E
-11
حجم السوق
7,643,141,011
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    I
    IONS
    -0.365
    (-1.12%)
    32.310 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    R
    RGEN
    -3.710
    (-2.28%)
    158.950 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    المزيد
الأخبار
المقالات

العنوان: Revolution Medicines

القطاع: Healthcare
الصناعة: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.